Select a Size
| Size/SKU | Availability | Price |
|---|---|---|
1 ea | Check Cart for Availability | $896.00 $896.00 |
About This Item
$896.00
agency
suitable for USP L1
Quality Segment
product line
Nucleosil®
feature
endcapped
manufacturer/tradename
Nucleosil®
extent of labeling
15% Carbon loading
parameter
≤70 °C temp. range, 400 bar pressure (5801 psi)
technique(s)
HPLC: suitable
L × I.D.
12.5 cm × 4 mm
surface area
350 m2/g
matrix
octadecyl
matrix active group
C18 (RP18), C18 (octadecyl) phase
particle size
5 μm
pore size
100 Å
separation technique
reversed phase
Application
- Quantification and Validation of Stability-Indicating RP-HPLC Method for Efavirenz: Demonstrates the utility of Nucleosil® C18 HPLC Column in pharmaceutical analysis, particularly in quality control and stability testing of Efavirenz, ensuring compliance with regulatory standards (Gurumukhi VC, Bari SB, 2022).
- Development of new method for simultaneous analysis of piracetam and levetiracetam: This study uses the Nucleosil® C18 column to develop robust methods for analyzing neurological medications in pharmaceuticals and biological fluids, contributing to drug stability studies (Siddiqui FA et al., 2014).
- HPLC method for determination of biologically active epoxy-transformers of treosulfan: The column′s application in plasma analysis highlights its role in pharmacokinetic studies, offering precise measurements critical for dosing and therapeutic monitoring (Główka FK et al., 2012).
- HPLC analysis of mitoxantrone in mouse plasma and tissues: Illustrates the column′s effectiveness in a pharmacokinetic study, underscoring its importance in the preclinical evaluation of cancer therapies (An G, Morris ME, 2010).
- Development and validation of an HPLC method for vancomycin: This application in a pharmacokinetic study highlights the column′s critical role in the development and validation of methods for antibiotic analysis, ensuring therapeutic efficacy and safety (Jesús Valle MJ et al., 2008).
Legal Information
1 of 1
This Item | |||
|---|---|---|---|
| description 5 μm particle size, L × I.D. 12.5 cm × 4 mm | description pore size 100 Å, 10 μm particle size, L × I.D. 25 cm × 4.6 mm | description 5 μm particle size, L × I.D. 25 cm × 4 mm | description pore size 100 Å, 5 μm particle size, L × I.D. 12.5 cm × 4.6 mm |
| particle size 5 μm | particle size 10 μm | particle size 5 μm | particle size 5 μm |
| separation technique reversed phase | separation technique reversed phase | separation technique reversed phase | separation technique reversed phase |
| matrix active group C18 (RP18), C18 (octadecyl) phase | matrix active group C18 (RP18), C18 (octadecyl) phase | matrix active group C18 (RP18), C18 (octadecyl) phase | matrix active group C18 (RP18), C18 (octadecyl) phase |
| L × I.D. 12.5 cm × 4 mm | L × I.D. 25 cm × 4.6 mm | L × I.D. 25 cm × 4 mm | L × I.D. 12.5 cm × 4.6 mm |
| pore size 100 Å | pore size 100 Å | pore size 100 Å | pore size 100 Å |
| technique(s) HPLC: suitable | technique(s) HPLC: suitable | technique(s) HPLC: suitable | technique(s) HPLC: suitable |
Still not finding the right product?
Explore all of our products under Nucleosil® C18 HPLC Column
Storage Class
11 - Combustible Solids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.